The world's leading healthcare company Abbott announced 2017 second quarter results, excluding the impact of currency, Abbott's global sales in the second quarter were $ 6.6 billion, an increase of 2.9% over the same period in 2016. The adjusted earnings achieved an increase of more than 10%. To this end, Abbott has raised the annual diluted earnings per share range to $2.43 to $2.53.
As seen in the earnings report, in the second quarter, Abbott’s medical device segment performed particularly well, with global sales reaching US$2.6 billion, up 3.2% year-on-year. Among them, the sales of products related to the diabetes care business increased by 25% year-on-year. Abbott’s nutritional products business achieved a small increase of 0.5% in the second quarter, reaching $1.7 billion. Driven by important pharmaceutical markets such as China, Brazil, Russia and India, Abbott’s global sales of the pharmaceuticals business in the second quarter reached $1 billion, an increase of 3.5% year-on-year. In the second quarter of the diagnostic business, global sales reached US$1.3 billion, a year-on-year increase of 5.4%.
Mr. Bai Qianli, Chairman and CEO of Abbott, said that in the blink of an eye, more than half of 2017, Abbott’s businesses are progressing as planned. After completing the acquisition of St. Jude, the company's overall sales growth is obvious to all. The company has adjusted its annual diluted equity income range to achieve the 2017 double-digit growth target.
Boiling Flask,Glass Boiling Flask,Round Bottom Boiling Flask,Borosilicate Glass Boiling Flask
Yancheng Rongtai Labware Co.,Ltd , https://www.shtestlab.com